Belite Bio Files 2024 Annual Report
Ticker: BLTE · Form: 20-F · Filed: Mar 17, 2025 · CIK: 1889109
| Field | Detail |
|---|---|
| Company | Belite Bio, INC (BLTE) |
| Form Type | 20-F |
| Filed Date | Mar 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, pharmaceutical
TL;DR
Belite Bio dropped its 2024 20-F, check financials for Q4.
AI Summary
Belite Bio, Inc. filed its 20-F annual report for the fiscal year ending December 31, 2024. The company, located at 12750 High Bluff Drive, Suite 475, San Diego, CA 92130, operates in the Pharmaceutical Preparations sector. The filing includes details on financial reporting under U.S. GAAP and references specific dates for financial events like inducement warrants and registered direct offerings.
Why It Matters
This 20-F filing provides investors with a comprehensive overview of Belite Bio's financial performance and operational status for the past fiscal year, crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Belite Bio faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the sector.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the reporting period for the 20-F.)
- 20250317 — Filing Date (The date the 20-F was officially submitted to the SEC.)
Key Players & Entities
- Belite Bio, Inc. (company) — Filer of the 20-F report
- 12750 High Bluff Drive Suite 475, San Diego, CA 92130 (location) — Business and mailing address
- 20241231 (date) — Fiscal year end
- 20250317 (date) — Filing date
- 2024-11-04 (date) — Date related to inducement warrants
- 2024-04-29 (date) — Date related to registered direct offering
FAQ
What is Belite Bio's primary business sector?
Belite Bio, Inc. is classified under Pharmaceutical Preparations [2834].
When did Belite Bio's fiscal year end for this report?
The fiscal year end was December 31, 2024.
What is the company's principal executive office address?
The business address is 12750 High Bluff Drive, Suite 475, San Diego, CA 92130.
What specific financial events are noted with dates in the filing data?
The filing data references dates such as 2024-11-04 for inducement warrants and 2024-04-29 for registered direct offerings.
What accounting standards does Belite Bio report under?
Belite Bio reports under U.S. GAAP.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 17, 2025 regarding BELITE BIO, INC (BLTE).